370 reports of this reaction
1.9% of all INSULIN GLULISINE reports
#9 most reported adverse reaction
NAUSEA is the #9 most commonly reported adverse reaction for INSULIN GLULISINE, manufactured by sanofi-aventis U.S. LLC. There are 370 FDA adverse event reports linking INSULIN GLULISINE to NAUSEA. This represents approximately 1.9% of all 19,263 adverse event reports for this drug.
Patients taking INSULIN GLULISINE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for INSULIN GLULISINE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for INSULIN GLULISINE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 370 FDA reports for INSULIN GLULISINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 1.9% of all adverse event reports for INSULIN GLULISINE, making it a notable side effect.
If you experience nausea while taking INSULIN GLULISINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.